A detailed history of Wolverine Trading, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Wolverine Trading, LLC holds 90,000 shares of MNKD stock, worth $616,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90,000
Previous 20,604 336.81%
Holding current value
$616,500
Previous $107,000 428.04%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.05 - $5.43 $33,849 - $45,383
-8,358 Reduced 28.86%
20,604 $107,000
Q1 2024

May 15, 2024

BUY
$3.25 - $5.27 $94,126 - $152,629
28,962 New
28,962 $131,000
Q3 2023

Nov 15, 2023

BUY
$3.91 - $5.45 $57,172 - $79,689
14,622 New
14,622 $60,000
Q3 2022

Nov 14, 2022

BUY
$2.99 - $4.35 $48,285 - $70,248
16,149 New
16,149 $48,000
Q4 2021

Feb 14, 2022

SELL
$4.05 - $5.37 $43,586 - $57,791
-10,762 Reduced 40.26%
15,972 $70,000
Q3 2021

Nov 12, 2021

BUY
$3.89 - $5.48 $4,310 - $6,071
1,108 Added 4.32%
26,734 $120,000
Q2 2021

Aug 06, 2021

SELL
$3.61 - $5.45 $127,541 - $192,548
-35,330 Reduced 57.96%
25,626 $134,000
Q1 2021

May 14, 2021

BUY
$3.14 - $6.14 $120,236 - $235,112
38,292 Added 168.96%
60,956 $222,000
Q4 2020

Feb 12, 2021

BUY
$1.79 - $4.04 $7,091 - $16,006
3,962 Added 21.18%
22,664 $76,000
Q3 2020

Nov 13, 2020

SELL
$1.56 - $2.08 $2,747 - $3,662
-1,761 Reduced 8.61%
18,702 $36,000
Q2 2020

Aug 13, 2020

BUY
$0.94 - $2.21 $8,411 - $19,775
8,948 Added 77.71%
20,463 $37,000
Q1 2020

May 11, 2020

BUY
$0.84 - $1.76 $9,672 - $20,266
11,515 New
11,515 $12,000
Q3 2018

Nov 14, 2018

SELL
$1.01 - $2.19 $23,551 - $51,066
-23,318 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$2.28 - $3.8 $186,314 - $310,524
-81,717 Reduced 77.8%
23,318 $53,000
Q4 2017

Feb 14, 2018

BUY
$2.28 - $6.71 $94,519 - $278,169
41,456 Added 65.2%
105,035 $244,000
Q3 2017

Nov 15, 2017

BUY
$1.15 - $2.29 $73,115 - $145,595
63,579
63,579 $138,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.76B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.